GlassScriptPhysician profile
Jaime C Morrison
NPI 1649365297
$1,386.87
in general payments reported to CMS, 2019-2025
19 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $372 · 2022: $379 · 2023: $165 · 2024: $289 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $253.30 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $154.95 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.31 | 2022-2024 | |
| Lilly USA, LLC | $131.27 | 2022-2025 | Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $110.89 | 2021-2024 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $93.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $82.31 | 2024-2025 | Airsupra, Farxiga |
| Pfizer INC. | $79.80 | 2021-2024 | |
| Eisai INC. | $54.83 | 2025 | |
| Exact Sciences Corporation | $53.17 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $40.20 | 2022-2023 | |
| Amgen INC. | $36.41 | 2024-2025 | Evenity, Prolia, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.20 | 2022 | |
| Idorsia Pharmaceuticals US INC | $24.98 | 2022 | |
| Amarin Pharma, INC. | $22.06 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.97 | 2022 | |
| Abbott Laboratories | $16.28 | 2022 | |
| Almatica Pharma LLC | $14.69 | 2024 | Loreev Xr |
| Kowa Pharmaceuticals America, INC. | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.